EMA approves 2 more Pfizer jab production sites

Tuesday, 22. June 2021 15:36

The European Medicines Agency announced on Tuesday it approved two more manufacturing sites for the production of the Pfizer/BioNTech COVID-19 vaccine.

The agency noted the sites in Reinbek, Germany, and Stein, Switzerland, will "perform finished product manufacturing steps at different stages of the process." The German site is operated by Allergopharma, while the Swiss one is operated by Novartis.

The EMA stressed that the two sites can start production immediately as the agency's decision is not subject to the approval of the European Commission.

Related Links: Novartis AGBioNTech SEPfizer Inc.
Baha Breaking News (BBN) / NP